US · Healthcare

Amarantus Bioscience Holdings Inc (AMBS)

Biotechnology

Amarantus Bioscience Holdings Inc (AMBS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AMBS

P/E ratio

18.00

Amarantus Bioscience Holdings Inc (AMBS) — FAQ

What is AMBS's P/E ratio?

The price-to-earnings (P/E) ratio for Amarantus Bioscience Holdings Inc (AMBS) is 18.00 (data as of 2026-03-23).

Does Amarantus Bioscience Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Amarantus Bioscience Holdings Inc (AMBS). Check the MyAverix Finance app for the latest dividend data.

What sector is Amarantus Bioscience Holdings Inc in?

Amarantus Bioscience Holdings Inc (AMBS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AMBS listed on?

AMBS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)